A carregar...
Cediranib – Profile of a novel anti-angiogenic agent in patients with glioblastoma
BACKGROUND: Treatment strategies targeting angiogenesis have revealed promising results in pre-clinical studies and early clinical trials in patients with glioblastomas. OBJECTIVE: This review evaluates the preclinical and clinical data for cediranib (AZD2171), a potent oral inhibitor of the vascula...
Na minha lista:
Main Authors: | , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
2009
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2761074/ https://ncbi.nlm.nih.gov/pubmed/19671039 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/13543780903183528 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|